THERAPEUTIC MAINTENANCE OF ABATACEPT IN RHEUMATOID ARTHRITIS: RESULTS OF THE RIC-ABA STUDY (517 PATIENTS)

Archive ouverte

Salmon, J. H. | Letarouilly, U. G. | Coquerelle, P. | Goeb, Vincent | Guyot, M. H. | Houvenagel, E. | Lecuyer, N. | Le Dantec, L. | Marguerie, L. | Morel, G. | Baudens, G. | Solau, E. | Flipo, R. -M.

Edité par CCSD ; BMJ Publishing Group -

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, NETHERLANDS, JUN 13-16, 2018. International audience

Consulter en ligne

Suggestions

Du même auteur

BIOLOGIC DISEASE-MODIFYING ANTIRHEUMATIC DRUGS IN PSORIATIC ARTHRITIS: A REAL-WORLD COHORT OF 439 PATIENTS

Archive ouverte | Letarouilly, J-G | CCSD

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, NETHERLANDS, JUN 13-16, 2018. International audience

DESCRIPTION IN REAL-WORLD OF THE EFFICACY AFTER SWITCHING FROM INTRAVENOUS TO SUBCUTANEOUS ADMINISTRATION OF TOCILIZUMAB IN PATIENTS WITH RHEUMATOID ARTHRITIS. THE ROSWITCH STUDY

Archive ouverte | Darloy, J. | CCSD

Congress of the European-League-Against-Rheumatism (EULAR), Amsterdam, NETHERLANDS, JUN 13-16, 2018. International audience

Predictive risk factors of serious infections in patients with rheumatoid arthritis treated with abatacept in common practice: results from the Orencia and Rheumatoid Arthritis (ORA) registry

Archive ouverte | Salmon, J. H. | CCSD

International audience. Objectives Little data are available regarding the rate and predicting factors of serious infections in patients with rheumatoid arthritis (RA) treated with abatacept (ABA) in daily practice....

Chargement des enrichissements...